Juniper Pharmaceuticals Inc (NASDAQ:JNP)

7.94
Delayed Data
As of 10:33am ET
 +0.4319 / +5.75%
Today’s Change
5.09
Today|||52-Week Range
8.40
+41.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line20.5M9.9M6.7M3.4M
 
 
 
 
 
Depreciation167.0K642.4K919.1K2.0M
 
 
 
 
 
Total Other Cash Flow-16.2M-5.1M-325.2K228.0K
 
 
 
 
 
Funds From Operations4.5M5.5M7.4M6.2M
 
 
 
 
 
Funds From/For Other Operating Expenses5.8M1.1M282.5K-777.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-1.3M4.3M7.1M6.9M
 
 
 
 
 
 
InvestingIncrease In Investments-15.1M-234.8K0.000.00
 
 
 
Decrease In Investments0.000.0015.4M0.00
 
 
Capital Expenditures-1.3M-985.9K-522.4K-2.0M
 
 
 
 
 
Fixed Asset Disposal3.1M0.000.000.00
 
 
Net Assets From Acquisitions 0.000.00-14.5M0.00
 
 
Net Cash Flow Investing-13.3M-1.2M315.1K-2.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.00----
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.00-72.3K-245.0K
 
 
 
Net Proceeds Stock Sale3.3M0.0010.7K33.0K
 
 
 
 
Common Preferred Redeemed-125.4K-50.0K0.00-8.5M
 
 
 
 
Common Dividends0.00-29.3K0.000.00
 
 
Cash Dividends Paid - Total-30.0K-29.3K-27.5K-28.0K
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing3.1M-79.3K-89.1K-8.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-7.7K46.1K212.7K-85.0K
 
 
 
 
 
 
Net Change In Cash-11.5M3.0M7.3M-3.9M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account